Clinical Trial Update: Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

View source ↗

Summary

This completed clinical trial update reports on the risk of breakthrough symptoms associated with long-acting injectable antipsychotics in people with schizophr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Schizophrenia Relapse

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Schizophrenia Relapse | Status: COMPLETED